These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1068629)

  • 1. Experimentally developed cellular resistance to daunomycin. Resistance mechanisms, the daunomycin-pump and cross resistance to adriamycin, vincristine and vinblastine.
    Dano K
    Acta Pathol Microbiol Scand Suppl; 1976; (256 Suppl):3-80. PubMed ID: 1068629
    [No Abstract]   [Full Text] [Related]  

  • 2. Correlations between cytotoxicity, biochemical effects, drug levels, and therapeutic effectiveness of daunomycin and adriamycin on Sarcoma 180 ascites in mice.
    Silvestrini R; Lenaz L; Di Fronzo G; Sanfilippo O
    Cancer Res; 1973 Nov; 33(11):2954-8. PubMed ID: 4748447
    [No Abstract]   [Full Text] [Related]  

  • 3. Multidrug resistance in a human small cell lung cancer cell line selected in adriamycin.
    Mirski SE; Gerlach JH; Cole SP
    Cancer Res; 1987 May; 47(10):2594-8. PubMed ID: 2436751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross resistance between vinca alkaloids and anthracyclines in Ehrlich ascites tumor in vivo.
    Dano K
    Cancer Chemother Rep; 1972 Dec; 56(6):701-8. PubMed ID: 4660629
    [No Abstract]   [Full Text] [Related]  

  • 5. Daunomycin pharmacological activity at the cellular level.
    Di Marco A
    Pathol Biol; 1967 Oct; 15(19):897-902. PubMed ID: 4297686
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of bisbenzylisoquinoline (biscoclaurine) alkaloids on multidrug resistance in KB human cancer cells.
    Shiraishi N; Akiyama S; Nakagawa M; Kobayashi M; Kuwano M
    Cancer Res; 1987 May; 47(9):2413-6. PubMed ID: 3567927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytogenetic investigations on a Ehrlich ascites tumor, and four sublines resistant to daunomycin, adriamycin, vincristine and vinblastine.
    Hasholt L; Dan0 K
    Hereditas; 1974; 77(2):303-10. PubMed ID: 4141349
    [No Abstract]   [Full Text] [Related]  

  • 8. DNA complexing antibiotics: daunomycin, adriamycin and their derivatives.
    Marco A; Arcamone F
    Arzneimittelforschung; 1975 Mar; 25(3):368-74. PubMed ID: 1174034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporin A reverses vincristine and daunorubicin resistance in acute lymphatic leukemia in vitro.
    Slater LM; Sweet P; Stupecky M; Gupta S
    J Clin Invest; 1986 Apr; 77(4):1405-8. PubMed ID: 3457021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adriamycin, an antitumour antibiotic: a review with special reference to daunomycin.
    Skovsgaard T; Nissen NI
    Dan Med Bull; 1975 Feb; 22(2):62-73. PubMed ID: 1093818
    [No Abstract]   [Full Text] [Related]  

  • 11. Cancer chemotherapy. II.
    Greenwald ES
    N Y State J Med; 1972 Nov; 72(21):2641-54. PubMed ID: 4117677
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical studies with daunorubicin-DNA and adriamycin-DNA complexes: a review.
    Trouet A; Sokal G
    Cancer Treat Rep; 1979 May; 63(5):895-8. PubMed ID: 287556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single cell analysis of daunomycin uptake and efflux in multidrug-resistant and -sensitive KB cells: effects of verapamil and other drugs.
    Willingham MC; Cornwell MM; Cardarelli CO; Gottesman MM; Pastan I
    Cancer Res; 1986 Nov; 46(11):5941-6. PubMed ID: 3756931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative biochemical studies of adriamycin and daunomycin in leukemic cells.
    Wang JJ; Chervinsky DS; Rosen JM
    Cancer Res; 1972 Mar; 32(3):511-5. PubMed ID: 5061305
    [No Abstract]   [Full Text] [Related]  

  • 15. Adriamycin (NSC-123127) and its analogs.
    Henry DW
    Cancer Chemother Rep 2; 1974 Dec; 4(4):5-9. PubMed ID: 4451911
    [No Abstract]   [Full Text] [Related]  

  • 16. Vindesine as a single agent and in combination with adriamycin in the treatment of metastatic breast carcinoma.
    Smith IE; Coombes RC; Evans BD; Ford HT; Gazet JC; Gordon C; McKinna JA; Powles TJ
    Eur J Cancer (1965); 1980; Suppl 1():271-3. PubMed ID: 7032939
    [No Abstract]   [Full Text] [Related]  

  • 17. [1973 treatment of acute leukemias].
    Danieli G
    Minerva Med; 1974 Dec; 65(90):4742-53. PubMed ID: 4141485
    [No Abstract]   [Full Text] [Related]  

  • 18. Acquisition of multiple drug resistance by CCRF-CEM cells selected for different degrees of resistance to vincristine.
    Conter V; Beck WT
    Cancer Treat Rep; 1984 Jun; 68(6):831-9. PubMed ID: 6539648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Establishment of adriamycin-resistant human small-cell lung cancer cells in culture: analysis of the mechanism of resistance and cross-resistance].
    Kimura I; Ohnoshi T; Hiraki S; Miyamoto H
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):830-6. PubMed ID: 3032107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of 4-demethoxy-11-deoxy-analogs of daunomycin and adriamycin.
    Umezawa H; Takahashi Y; Konoshita M; Naganawa H; Tatsuta K; Takeuchi T
    J Antibiot (Tokyo); 1980 Dec; 33(12):1581-5. PubMed ID: 7195898
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.